Comments
The initial public offering of Tatva Chintan Pharma Chem witnessed huge investor interest, with the issue getting fully subscribed with hours of opening and finally closing with 4.51 times subscription on day 1 of issue on Friday.
The ₹500-crore IPO received bids for 1.47 crore shares as compared to 32.62 lakh shares on offer. The qualified institutional buyers portionwas subscribed 50 per cent, while the non-institutional investors’ category received 1.14 times and those for retail investors 8.24 times, according to NSE data.
The offer is in a price range of ₹1,073-1,083 a share.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.